DermaSensor, Inc.

Thank you to everyone who visited the DermaSensor booth at #AAD2026. The conversations around early skin cancer detection and the importance point-of-care technology were incredible. Learn more: hubs.li/Q0492D1d0​ #Dermatology #SkinCancer #MedTech

We're heading to Orlando! Find DermaSensor at Booth #716 at the Henry Schein National Sales Meeting — March 26–28. Meet our CCO & SVP of Sales and Business Development​ @HenrySchein #DermaSensor #HenryScheinNSM2026 #PCP #MedTech

Denver, we're here! Heading to #AAD2026. ​ Stop by Booth #451, 27th March - 29th March and connect with the DermaSensor team.​ @AADskin #DermaSensor #PrimaryCare #PCP #AAD2026 #MedTech

Excited to share that Cody Simmons, CEO at @DermaSensor will present at LSI USA ’26 in Dana Point.​ 📍 Waldorf Astoria Monarch Beach​ 📅 Mar 16–20​ #LSIUSA26​ #medicaldevice #medtech #medicaltechnology @lsintelligence

This International Women’s Day, prioritize your skin health.​ If you notice a new or changing spot, consider having it assessed by your primary care physician.​ Find a physician using DermaSensor: hubs.li/Q045XkqQ0​ #InternationalWomensDay #SkinHealth #EarlyAssessment

Patients bring photos. Clinicians need clarity.​ Objective skin assessment helps reduce uncertainty during routine visits.​ hubs.li/Q045n_df0​ #EarlyDetection #PrimaryCare #DigitalHealth

We’re attending @theviveevent in Los Angeles!​ 📍 Kiosk #2242–5 | Feb 23–25​ Stop by to see how DermaSensor helps primary care physicians assess suspicious skin lesions objectively, right at the point of care.​ Let’s connect at ViVE! #ViVEvent #MedTech #HealthInnovation

We’re exhibiting at the 2026 @acgme Annual Educational Conference in San Diego!​ 📍 Booth #182 | Feb 20–21​ Stop by to see how @DermaSensor supports PCPs with point-of-care skin cancer risk detection designed for real clinical workflows.​ #ACGME2026 #MedTech #PointOfCare

Proud moment for @DermaSensor & Congrats @codyVsimmons, Co-Founder & CEO of DermaSensor, on being named a 2025 Top Industry Leader by @LifeSciencesVo.​ 🎉​ Grateful to be part of a community advancing innovation in healthcare and primary care.​ #HealthcareInnovation #MedTech

On #WorldCancerDay, early detection starts with awareness—especially in primary care.​ ✔️ Regular skin checks​ ✔️ Sun protection​ ✔️ Patient education​ 👉 Find a physician using DermaSensor near you:​ hubs.li/Q041MXbK0​ #SkinCancerAwareness #PrimaryCare #EarlyDetection

Honored to be recognized by @Inc as a 2025 #BestInBusiness Award recipient in the Best in Innovation category. This milestone reflects our mission to make skin cancer detection more accessible in primary care. See the full list: hubs.ly/Q03WH6jK0 #MedTech #SkinCancer

Boston University highlighted the early photonics research that helped shape the DermaSensor device. In the video, Prof. Irving Bigio shares how this technology began in the lab and is now supporting primary care. Learn more: hubs.li/Q03Wwxxf0 #HealthTech #SkinCancer

AI in dermatology is advancing quickly, but strong FDA oversight is crucial. Duke’s new JAAD article underscores this need. DermaSensor is one of the few FDA cleared AI tools, backed by a 1,000+ patient trial showing 96% sensitivity. Read: hubs.li/Q03VtkVK0 #medtech #JAAD

Dr. Bret Kueber shares how DermaSensor helps him assess suspicious lesions in seconds — with zero workflow disruption and instant results patients trust. Watch his story and see why he recommends it. 👇 #Skincancer #HealthTech #DigitalHealth #MedTech #HealthcareInnovation

Two new studies in JAAD International & JCAD confirm the consistent performance of DermaSensor’s FDA cleared, AI-powered device — improving physicians’ melanoma detection and confidence. 📄 Read more: hubs.li/Q03RVMNm0 #SkinCancerDetection #AIinHealthcare #PrimaryCare

1 in 5 Americans will develop skin cancer by age 70. Early detection starts with awareness and the right tools. DermaSensor helps physicians non-invasively assess suspicious skin in seconds. Find a provider near you: hubs.li/Q03QPW6V0 #SkinCancerAwareness #DermaSensor

Evaluating suspicious skin lesions can be challenging - visual exams are subjective and training varies. DermaSensor’s FDA-cleared AI device delivers objective insights to assess skin-cancer risk in real time. Learn more: hubs.li/Q03P5NzS0 #AIhealth #SkinCancer #MedTech

This week, our CEO, Cody Simmons, participated in discussions on innovation at AdvaMed’s MedTech Conference in San Diego. We are proud to contribute to conversations that advance healthcare. Learn more at hubs.li/Q03MZJZS0. #AdvaMed #MedTech #Innovation #Skincancer

Big news from DermaSensor! We’ve raised $16 million in Series B funding, bringing our total to $43 million — fueling the expansion of our FDA cleared, handheld skin cancer detection device. Read more: hubs.li/Q03LWc-y0 #HealthTech #AIinHealthcare #DigitalHealth #SeriesB

Honored to sponsor this year’s Private Physicians Alliance Meeting! Our FDA-cleared, AI-powered device brings real-time skin cancer risk assessment to the point of care. Thanks Dr. Brian Hollett, MD for showing its impact in practice. #HealthTech #Innovation #MedicalDevices